Johnson & Johnson

 

Non-Small Cell Lung Cancer
22:09

Johnson & Johnson

Proactive Management of Dermatologic Adverse Reactions for Patients on an EGFR+ mNSCLC Therapy

FEATURING Amanda Edmond
  • October 31, 2025
21:03

Johnson & Johnson

Proactive Therapy Management of Infusion-Related Reactions in Patients Receiving Treatment for mNSCLC

FEATURING Jun Zhang
  • 1 view
  • October 27, 2025